STOCK TITAN

Perimeter Medical Imaging AI to Report Third Quarter 2024 Financial Results and Host Conference Call on November 14, 2024

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings AI

Perimeter Medical Imaging AI (TSXV: PINK)(OTC: PYNKF) announced it will release its third quarter 2024 financial results after market close on November 14, 2024. The company will host a conference call and webcast at 5:00 pm Eastern Time to discuss the results and provide a corporate update. Investors can access the call via 1-800-717-1738 (Canada/US) or 1-646-307-1865 (International). The webcast will be available on the company's website under the Investors section.

Perimeter Medical Imaging AI (TSXV: PINK)(OTC: PYNKF) ha annunciato che rilascerà i suoi risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato il 14 novembre 2024. L'azienda terrà una conferenza telefonica e un webcast alle 17:00 ora orientale per discutere i risultati e fornire aggiornamenti aziendali. Gli investitori possono accedere alla chiamata tramite il numero 1-800-717-1738 (Canada/US) o 1-646-307-1865 (internazionale). Il webcast sarà disponibile sul sito web dell'azienda nella sezione Investitori.

Perimeter Medical Imaging AI (TSXV: PINK)(OTC: PYNKF) anunció que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el 14 de noviembre de 2024. La compañía llevará a cabo una llamada de conferencia y un webcast a las 5:00 pm hora del Este para discutir los resultados y proporcionar una actualización corporativa. Los inversores pueden acceder a la llamada a través del 1-800-717-1738 (Canadá/EE. UU.) o 1-646-307-1865 (Internacional). El webcast estará disponible en el sitio web de la empresa en la sección de Inversores.

Perimeter Medical Imaging AI (TSXV: PINK)(OTC: PYNKF)는 2024년 3분기 재무 결과2024년 11월 14일 시장 마감 후 발표할 것이라고 발표했습니다. 회사는 결과를 논의하고 기업 업데이트를 제공하기 위해 동부 표준시 기준 오후 5시에 컨퍼런스 콜 및 웹캐스트를 개최합니다. 투자자는 1-800-717-1738(캐나다/미국) 또는 1-646-307-1865(국제)로 전화를 통해 접속할 수 있습니다. 웹캐스트는 회사 웹사이트의 투자자 섹션에서 이용할 수 있습니다.

Perimeter Medical Imaging AI (TSXV: PINK)(OTC: PYNKF) a annoncé qu'elle publiera ses résultats financiers du troisième trimestre 2024 après la fermeture du marché le 14 novembre 2024. La société organisera une conférence téléphonique et un webinaire à 17h00, heure de l'Est, pour discuter des résultats et fournir une mise à jour sur l'entreprise. Les investisseurs peuvent accéder à l'appel au 1-800-717-1738 (Canada/États-Unis) ou au 1-646-307-1865 (international). Le webinaire sera disponible sur le site Web de l'entreprise dans la section Investisseurs.

Perimeter Medical Imaging AI (TSXV: PINK)(OTC: PYNKF) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 nach Marktschluss am 14. November 2024 veröffentlichen wird. Das Unternehmen wird um 17:00 Uhr Eastern Time eine Telefonkonferenz und einen Webcast abhalten, um die Ergebnisse zu besprechen und ein Unternehmensupdate zu geben. Anleger können über die Nummer 1-800-717-1738 (Kanada/USA) oder 1-646-307-1865 (international) auf die Konferenz zugreifen. Der Webcast wird auf der Website des Unternehmens im Bereich Investoren verfügbar sein.

Positive
  • None.
Negative
  • None.

Perimeter Medical Imaging AI Logo (CNW Group/Perimeter Medical Imaging AI Inc.)

TORONTO and DALLAS, Nov. 8, 2024 /PRNewswire/ - Perimeter Medical Imaging AI, Inc. (TSXV: PINK)(OTC: PYNKF) ("Perimeter" or the "Company"), a commercial-stage medical technology company,  announced it will report its third quarter 2024 financial and operating results after market close on Thursday, November 14, 2024. Following the announcement, Perimeter management will host a webcast and conference call to discuss the results and provide a corporate update.

Third Quarter 2024 Results Conference Call Details:

Date:                           Thursday, November 14, 2024

Time:                           5:00 pm Eastern Time

Dial-In Numbers:        1-800-717-1738 (Canada and the United States) or 1-646-307-1865 (International)

The call will also be broadcast live and archived on the Company's website under "News/Events" in the Investors section.

About Perimeter Medical Imaging AI, Inc. 
Based in Toronto, Canada and Dallas, Texas, Perimeter Medical Imaging AI (TSX-V: PINK) (OTC: PYNKF) (FSE: 4PC) is a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the U.S., our FDA-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents our next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to US$7.4 million awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements
This news release contains statements that constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may," "would," "could," "will," "likely," "believe," "expect," "anticipate," "intend," "plan," "estimate," and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may relate to management's future outlook and anticipated events or results and may include statements or information regarding the future financial position, business strategy and strategic goals, competitive conditions, research and development activities, projected costs and capital expenditures, research and clinical testing outcomes, taxes and plans and objectives of, or involving, Perimeter. Without limitation, information regarding the potential benefits of Perimeter S-Series OCT, Perimeter B-Series OCT, and Perimeter ImgAssist are forward-looking information. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, any particular result will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions, and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market, and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described in Perimeter's Management Discussion and Analysis for the year ended December 31, 2023, which is available on Perimeter's SEDAR+ profile at https://www.sedarplus.ca, and could cause actual events or results to differ materially from those projected in any forward-looking statements. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.

CONTACTS:

Stephen Kilmer
Investor Relations
Telephone: 888-545-6374 or 647-872-4849
Email: skilmer@perimetermed.com

Adrian Mendes
Chief Executive Officer
Toll-free: 888-988-7465 (PINK)
Email: investors@perimetermed.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perimeter-medical-imaging-ai-to-report-third-quarter-2024-financial-results-and-host-conference-call-on-november-14-2024-302299799.html

SOURCE Perimeter Medical Imaging AI Inc.

FAQ

When will Perimeter Medical Imaging AI (PYNKF) report Q3 2024 earnings?

Perimeter Medical Imaging AI will report its Q3 2024 earnings after market close on Thursday, November 14, 2024.

How can investors join Perimeter Medical Imaging AI's (PYNKF) Q3 2024 earnings call?

Investors can join the call on November 14, 2024, at 5:00 pm ET by dialing 1-800-717-1738 (Canada/US) or 1-646-307-1865 (International), or via webcast on the company's website.

PERIMETER MED IMAGING AI

OTC:PYNKF

PYNKF Rankings

PYNKF Latest News

PYNKF Stock Data

38.28M
80.87M
13.3%
33.23%
Medical Devices
Healthcare
Link
United States of America
Toronto